Finance entity
markets is the sole category represented across all 2 tracked stories. Chris Beauchamp is most often covered alongside AstraZeneca, which appears in 1 of these 2 stories. The 13-day window averages about 1.1 stories each week. At 7.5, the average consequence score sits above the same-window beat average of 6.
Last mentioned: Aug 3, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 2 tracked stories. Chris Beauchamp is most often covered alongside AstraZeneca, which appears in 1 of these 2 stories. The 13-day window averages about 1.1 stories each week. At 7.5, the average consequence score sits above the same-window beat average of 6. Source depth averages 3 original sources per story, versus 2.6 across the same-window beat baseline. Chris Beauchamp appears in 2 tracked Finance stories published from July 22, 2026 through August 3, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 234 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Chris Beauchamp. Shared-story counts are live from our verified record — not editorial picks.
AstraZeneca shares plummeted in London trading after reports of merger talks with Bristol Myers Squibb, as the market priced in execution risk, regulatory peril, and potential overpayment for a deal that would create a £300bn giant.
Equities rallied on July 21, 2026, with the S&P 500 up 0.9% despite Brent crude spiking to $91.99/barrel after Iran intensified attacks in the Gulf. Strong earnings from General Motors and a tech rebound overshadowed geopolitical risks, with analysts flagging an unusual decoupling that could reshape sector bets.
Chris Beauchamp is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
